Early detection aims to efficiently identify cancer.
Ophtascan screening technology is the first clinically tested and validated on-demand and real-time cancer screening system.
The Impact of Cancer and the Importance of Early Diagnosis
In 2020, there were approximately 19.3 million new cancer cases and nearly 10.0 million cancer deaths (excluding nonmelanoma skin cancer) worldwide. This staggering number highlights the urgent need for effective cancer screening and early detection methods.
Experience Unmatched Accuracy With Ophtascan’s AI-powered Cancer Screening
- Ophtascan Screening System is the First Clinically Tested and Validated On-demand and Real-time Cancer Screening System.
- The System is AI Driven, Backed by an Advanced Software Algorithm That Performs Micro-analysis of the Iris and Sclera in the Human Eye.
- The Ophtascan AI Algorithm is Designed to Give a Cancer Screening Result With a +95% Precision Rate.
How Ophtascan Works?
Experience Precision in Early Detection.
Step 01
A lab technician fits the OncoLenz headset on the patient and captures a detailed image of the eye.
Step 02
The captured image is securely uploaded to the Ophtascan cloud for analysis.
Step 03
Our sophisticated AI technology examines the image for biomarkers, detecting precancerous or cancerous conditions.
Step 04
A physician reviews the AI-generated results and communicates the findings to the patient.
Transform Cancer Screening
Book a Demo to See How Ophtascan Enhances Hospital Cancer Detection
Patented, Non-Invasive Cancer Screening Technology
- A groundbreaking, patented solution that sets a new standard in real-time cancer detection.
- Ophtascan offers a seamless, fast, and highly effective screening process, utilizing advanced computer vision to detect critical biomarkers.
- Powered by AI, our deep learning algorithm continually improves accuracy with every case.
- Capable of detecting multiple cancer types, providing comprehensive and non-invasive screening in a single platform.
Frequent Asked Questions
Ophtascan’s AI algorithm has a precision rate of over +95%, making it one of the most reliable cancer screening tools available.
Yes, Ophtascan’s Algorithm is Designed to Screen for Various Types of Cancer Such as Breast, Lungs, Uterine, Cervical and Prostate by Analyzing Distinct Patterns in the Eyes.
Yes, Ophtascan is the first cancer screening system of its kind to be clinically tested and validated, ensuring its reliability and effectiveness in real-world settings. It has been certified by the European Commison as a CE Class 1 Medical Device.
Affordable Excellence
Delivering top-tier cancer screening at an accessible cost for everyone.
+ 46 761 333 396
Prefer to send an email? Reach out to us at.
info@oncotechglobal.com